English | Español
Patient Daily | Feb 19, 2026

Common interview missteps cost biopharma job seekers opportunities
Patient Daily | Feb 19, 2026

Muscle preservation emerges as key challenge in next-generation obesity drug development
Patient Daily | Feb 19, 2026

New heart valve gives suburban woman renewed health after advanced treatment
Patient Daily | Feb 18, 2026

Disc Medicine's bitopertin rejection highlights questions around FDA's national priority voucher
Patient Daily News Service | Feb 18, 2026

Taxpayer advocate: ‘If every vaccine is sued out of existence, there will be zero incentive to bring new products to market’
Patient Daily | Feb 17, 2026

Preventive measures aim to reduce artificial joint infections after replacement surgeries
Patient Daily | Feb 17, 2026

FDA refusal prompts global shift among advanced therapy developers
Patient Daily | Feb 17, 2026

Northwestern Medicine expands Lake Forest Hospital with two new pavilions

Trending
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+ Pharmaceuticals
Patient Daily | Apr 1, 2026

Biopharma mergers and acquisitions reach $46.8 billion in first quarter of 2026
+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'